Nura Bio raises $68M for clinical tests of SARM1 inhibitor to potentially slow or prevent nerve degeneration

Plus, news about TScan Ther­a­peu­tics, Con­nect Bio­Phar­ma, The­olyt­ics and Ul­ti­movacs: In­tra-Cel­lu­lar Ther­a­pies seeks $500M of­fer­ing: Short­ly af­ter dis­clos­ing a Phase 3 win in de­pres­sion, which

Celebri­ty spokes­peo­ple, in­clud­ing La­dy Gaga, Taye Dig­gs and Jamie-Lynn Sigler, helped phar­ma brands hit red car­pet-wor­thy ad ef­fec­tive­ness rates, ac­cord­ing to a new analy­sis by